Hammarström L E, Stridbeck H, Ihse I
Department of Surgery, University Hospital, Lund, Sweden.
Eur J Surg. 1997 Aug;163(8):577-89.
To elucidate further the role of endoscopy in the treatment of benign pancreatic disease.
Retrospective study.
University hospital, Sweden.
136 of 319 patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) for known or suspected pancreatic disease had abnormal findings at duodenoscopy or ductography, or both. In 28 patients endoscopic treatment was considered because of recurrent acute pancreatitis (n = 6), chronic pancreatitis (n = 5), pancreatic pain syndrome (n = 5), pancreatic fistula with ascites (n = 1), and pseudocyst (n = 1), or appreciable biliary obstruction from chronic pancreatitis (n = 10).
Pancreatic duct drainage was attempted in 18 patients and successful in 13 (72%). Endoscopic sphincterotomy (EST) alone was done in 7/13 patients and an endoprosthesis (stent) was placed in 6/13. Bile duct drainage was attempted and successful in 10 patients by EST together with dilatation with (n = 6) or without (n = 4) simultaneous placement of a stent.
Relief of pain and cholestasis.
Immediate (1-30 days after initial treatment) and medium term (median 48 months after initial treatment) outcome after pancreatic duct drainage was excellent (no pain) or good (occasional mild pain) in 62% (8/13) and 67% (8/12) of the patients, respectively. Complications of the endoscopic procedure were encountered in four patients (31%) and comprised infection with abscess formation (n = 1), repeated stent clogging (n = 1) or stent migration (n = 2). Surgery was subsequently required in three patients (23%) because of intraabdominal abscess (n = 1), recurrent pain (n = 1), or no pain relief (n = 1). At medium term follow-up (median 68 months) after biliary drainage 7/10 patients had liver function tests within the reference ranges. Only two patients required subsequent biliodigestive shunts 7 and 13 months after EST, respectively.
Our findings favour endoscopic drainage as a safe and effective method for temporary and medium term relief of pain and biliary obstruction in selected patients with benign pancreatic disease.
进一步阐明内镜检查在良性胰腺疾病治疗中的作用。
回顾性研究。
瑞典大学医院。
319例因已知或疑似胰腺疾病接受内镜逆行胰胆管造影(ERCP)的患者中,136例在十二指肠镜检查或胰管造影或两者检查中发现异常。28例患者因复发性急性胰腺炎(n = 6)、慢性胰腺炎(n = 5)、胰腺疼痛综合征(n = 5)、伴有腹水的胰瘘(n = 1)、假性囊肿(n = 1)或慢性胰腺炎导致的明显胆管梗阻(n = 10)而考虑进行内镜治疗。
18例患者尝试进行胰管引流,13例(72%)成功。13例患者中7例单独进行内镜括约肌切开术(EST),6例放置内支架。10例患者通过EST联合扩张(n = 6)或不联合放置支架(n = 4)尝试并成功进行胆管引流。
疼痛缓解和胆汁淤积缓解情况。
胰管引流后即时(初始治疗后1 - 30天)和中期(初始治疗后中位48个月)结果分别为62%(8/13)和67%(8/12)的患者效果极佳(无疼痛)或良好(偶尔轻度疼痛)。4例患者(31%)出现内镜操作并发症,包括感染伴脓肿形成(n = 1)、支架反复堵塞(n = 1)或支架移位(n = 2)。3例患者(23%)随后因腹腔内脓肿(n = 1)、复发性疼痛(n = 1)或疼痛未缓解(n = 1)而需要手术治疗。胆管引流中期随访(中位68个月)时,10例患者中有7例肝功能检查在参考范围内。仅2例患者分别在EST后7个月和13个月需要进行胆肠分流术。
我们的研究结果支持内镜引流作为一种安全有效的方法,可在部分良性胰腺疾病患者中实现疼痛和胆管梗阻的短期及中期缓解。